Genmab Soars to Record Highs After Cancer Drug Succeeds in Key Trial
Genmab’s market capitalization surged by over $7 billion following positive trial results for a recently-acquired…
Newswire
RFK Jr backs compounding of six unapproved peptides in new policy
In a significant move for the pharmaceutical compounding sector, Robert F. Kennedy Jr. has endorsed…
Gaelic Labs: the EU Critical Medicines Act will have a positive impact on supply
Gaelic Labs anticipates significant advantages stemming from the EU’s Critical Medicines Act, which aims to…
HHS to Allow Compounders to Make 6 Unapproved Peptides
The U.S. Department of Health and Human Services (HHS) has announced that it will not…
IDWeek 2026: Abrysvo Data in Nursing Home Residents Could Support Re-vaccination
Abrysvo, a respiratory syncytial virus (RSV) vaccine, was first approved in the United States in…
FDA Issues Guidance on Essential Drug Delivery Performance Characteristics for Devices
The FDA has released new guidance aimed at enhancing the development of stand-alone devices and…
Kennedy’s Rally Highlights Growing Opposition to Vaccines and Big Agriculture Ahead of 2026 Midterms
On Wednesday night in Clive, Iowa, a gathering of Make America Healthy Again activists and…
AAV Gene Therapies Demand New Strategies for Sustainable Development
Adeno-associated virus (AAV) gene therapies have transformed the treatment landscape for rare and genetic diseases,…
Hamburg Hosts 2026 European Gene Therapy Conference
HAMBURG—The historic German port city of Hamburg is playing host to the European Society of…
Adial Pharmaceuticals Rebrands as Azora Therapeutics Ahead of Planned Clinical Trial
Adial Pharmaceuticals has officially rebranded as Azora Therapeutics, with Matt Davidson appointed as president and…